Evidence map›Paper›PMID 33370229›Full record

ArticleBlood transfusion = Trasfusione del sangue2021

AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update.

Paolo Caraceni, Paolo Angeli, Daniele Prati, Mauro Bernardi, Pierluigi Berti, Francesco Bennardello, Francesco Fiorin, Pierluigi Piccoli, Italian Association for the Study of the Liver (AISF), on behalf of the Italian Society of Transfusion Medicine and Immunohaematology (SIMTI)

Abstract readConsensus Statement
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Efficacy of albumin use in decompensated cirrhosis and real-world adoption in Australia.JGH open : an open access journal of gastroenterology and hepatology · 2024
    Review
  3. Review
  4. Evidence-based hyponatremia management in liver disease.Clinical and molecular hepatology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paolo CaraceniDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Paolo AngeliDepartment of Medicine, University of Padua, Padua, Italy.
Daniele PratiDepartment of Transfusion Medicine and Haematology, Fondazione IRCCS Ca' Granda Ospedale, Maggiore Policlinico, Milan, Italy.
Mauro BernardiDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Pierluigi BertiImmunohaematology and Transfusion Service, Aosta, Italy.
Francesco BennardelloImmunohaematology and Transfusion Medicine Centre, Provincial Health Authority, Ragusa, Italy.
Francesco FiorinTransfusion Service, Vicenza, Italy.
Pierluigi PiccoliTransfusion Medicine Unit, University Hospital of Verona, Verona, Italy.
Italian Association for the Study of the Liver (AISF), on behalf of the Italian Society of Transfusion Medicine and Immunohaematology (SIMTI)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease ManagementEvidence-Based PracticeHumansItalyLiver CirrhosisSerum Albumin, HumanSerum Albumin, Human

Identifiers

PMID33370229
PMCPMC7850931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.